OnTrackCF: Engagement, Feasibility, and Acceptability Study
Recruiting now · Not applicable
Conditions studied: Cystic Fibrosis (CF), Cystic Fibrosis - Complete
In brief
This is a multi-site, nonrandomized study using mixed methods approach to evaluate the feasibility, acceptability, and user engagement of OnTrackCF for adults with Cystic Fibrosis (AWCF).
Key facts
- Study ID
- NCT07031323
- Run by
- Boston Children's Hospital
- People needed
- 60
- Starts
- 2025-11-20
- Expected to finish
- 2026-12-01
- Last updated by the study team
- 2025-12-05
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Diagnosed with CF
- 18+ years of age
- Prescribed a CFTR modulator therapy to be taken twice a day
- Can speak and read English
- Have regular access to an iOS or Android tablet or smartphone with internet access.
You may not qualify if…
- Any situation, in the opinion of the Investigator, that would compromise the safety of the patient or the quality of the data
Where it is running
- Boston Children's Hospital — Boston, Massachusetts, United States (enrolling)
- University of Alabama-Birmingham — Birmingham, Alabama, United States
- Johns Hopkins University — Baltimore, Maryland, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.